Sanders Robert D, Xu Jing, Shu Yi, Januszewski Adam, Halder Sunil, Fidalgo Antonio, Sun Pamela, Hossain Mahmuda, Ma Daqing, Maze Mervyn
Department of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London, London, UK.
Anesthesiology. 2009 May;110(5):1077-85. doi: 10.1097/ALN.0b013e31819daedd.
Neuroapoptosis is induced by the administration of anesthetic agents to the young. As alpha2 adrenoceptor signaling plays a trophic role during development and is neuroprotective in several settings of neuronal injury, the authors investigated whether dexmedetomidine could provide functional protection against isoflurane-induced injury.
Isoflurane-induced injury was provoked in organotypic hippocampal slice cultures in vitro or in vivo in postnatal day 7 rats by a 6-h exposure to 0.75% isoflurane with or without dexmedetomidine. In vivo, the alpha2 adrenoceptor antagonist atipamezole was used to identify if dexmedetomidine neuroprotection involved alpha2 adrenoceptor activation. The gamma-amino-butyric-acid type A antagonist, gabazine, was also added to the organotypic hippocampal slice cultures in the presence of isoflurane. Apoptosis was assessed using cleaved caspase-3 immunohistochemistry. Cognitive function was assessed in vivo on postnatal day 40 using fear conditioning.
In vivo dexmedetomidine dose-dependently prevented isoflurane-induced injury in the hippocampus, thalamus, and cortex; this neuroprotection was attenuated by treatment with atipamezole. Although anesthetic treatment did not affect the acquisition of short-term memory, isoflurane did induce long-term memory impairment. This neurocognitive deficit was prevented by administration of dexmedetomidine, which also inhibited isoflurane-induced caspase-3 expression in organotypic hippocampal slice cultures in vitro; however, gabazine did not modify this neuroapoptosis.
Dexmedetomidine attenuates isoflurane-induced injury in the developing brain, providing neurocognitive protection. Isoflurane-induced injury in vitro appears to be independent of activation of the gamma-amino-butyric-acid type A receptor. If isoflurane-induced neuroapoptosis proves to be a clinical problem, administration of dexmedetomidine may be an important adjunct to prevent isoflurane-induced neurotoxicity.
给幼龄动物使用麻醉剂可诱导神经细胞凋亡。由于α2肾上腺素能受体信号在发育过程中发挥营养作用,且在多种神经元损伤情况下具有神经保护作用,作者研究了右美托咪定是否能对异氟烷诱导的损伤提供功能保护。
在体外器官型海马切片培养物中或在出生后第7天的大鼠体内,通过6小时暴露于0.75%异氟烷(加或不加右美托咪定)来引发异氟烷诱导的损伤。在体内,使用α2肾上腺素能受体拮抗剂阿替美唑来确定右美托咪定的神经保护作用是否涉及α2肾上腺素能受体激活。在异氟烷存在的情况下,还将γ-氨基丁酸A型拮抗剂加巴喷丁添加到器官型海马切片培养物中。使用裂解的半胱天冬酶-3免疫组织化学评估细胞凋亡。在出生后第40天使用恐惧条件反射在体内评估认知功能。
在体内,右美托咪定剂量依赖性地预防了异氟烷诱导的海马、丘脑和皮质损伤;这种神经保护作用被阿替美唑治疗减弱。虽然麻醉处理不影响短期记忆的获得,但异氟烷确实诱导了长期记忆损害。右美托咪定的给药可预防这种神经认知缺陷,其还在体外器官型海马切片培养物中抑制异氟烷诱导的半胱天冬酶-3表达;然而,加巴喷丁并未改变这种神经细胞凋亡。
右美托咪定减轻发育中大脑的异氟烷诱导损伤,提供神经认知保护。体外异氟烷诱导的损伤似乎与γ-氨基丁酸A型受体的激活无关。如果异氟烷诱导的神经细胞凋亡被证明是一个临床问题,右美托咪定的给药可能是预防异氟烷诱导的神经毒性的重要辅助手段。